表纸
市场调查报告书

全球孕妇用维他命市场 2018年~2022年

Global Prenatal Vitamin Supplements Market

出版商 TechNavio (Infiniti Research Ltd.) 商品编码 359360
出版日期 内容资讯 英文 120 Pages
商品交期: 最快1-2个工作天内
价格
Back to Top
全球孕妇用维他命市场 2018年~2022年 Global Prenatal Vitamin Supplements Market
出版日期: 2020年02月13日内容资讯: 英文 120 Pages
简介

孕妇用维他命市场

孕妇用维他命供给希望怀孕的女性、孕妇、产后的母乳育儿适合女性的必要维他命和矿物质。

Technavio分析师预测,在2018年到2022年间,全球孕妇用维他命市场将以8.6%的年复合成长率发展。

本报告提供全球孕妇用维他命市场调查,提供市场概要,各通路、各地区的市场规模变化与预测,市场趋势,市场成长要素及课题分析,竞争情形,主要企业的简介等全面性资讯。

目录

第1章 摘要整理

第2章 调查范围

第3章 调查方法

第4章 市场情形

  • 市场生态系统
  • 市场特性
  • 市场区隔分析

第5章 市场规模

  • 市场定义
  • 市场规模
  • 市场规模的预测

第6章 波特的五力分析

  • 买方议价能力
  • 供给企业谈判力
  • 新加入业者的威胁
  • 替代品的威胁
  • 竞争企业间的敌对关系
  • 市场情形

第7章 市场区隔:各销售管道

  • 市场区隔:各销售管道
  • 市场比较:各销售管道
  • 传统的零售
  • 直销、电子商务
  • 市场机会:各销售管道

第8章 客户形势

第9章 地区形势

  • 市场区隔:各地区
  • 市场比较:各地区
  • 南北美洲
  • 欧洲、中东、非洲
  • 亚太地区
  • 市场牵引国
  • 美国
  • 加拿大
  • 英国
  • 市场机会

第10章 决策架构

第11章 成长要素与课题

  • 市场成长要素
  • 市场课题

第12章 市场趋势

  • 孕妇用维他命补充品的增加
  • 维他命制造企业的AI利用
  • 受核准的维他命增加

第13章 业者情势

  • 概要
  • 创造性破坏状况

第14章 供应商分析

  • 交易厂商
  • 供应商分类
  • 供应商的市场定位
  • ATRIUM INNOVATIONS
  • Bayer
  • Church & Dwight
  • MegaFood
  • Nordic Naturals
  • Nutranext
  • 大冢集团
  • Procter & Gamble

第15章 附录

  • 简称的清单

本网页内容可能与最新版本有所差异。详细情况请与我们联系。

目录
Product Code: IRTNTR41009

Technavio has been monitoring the global prenatal vitamin supplements market and it is poised to grow by USD 195.69 mn during 2020-2024, progressing at a CAGR of 8% during the forecast period. Our reports on global prenatal vitamin supplements market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by increasing number of gynecologists recommending prenatal vitamin supplements to expecting mothers.

In addition, usage of artificial intelligence by prenatal vitamin supplement manufacturing players is anticipated to boost the growth of the global prenatal vitamin supplements market as well.

Market Segmentation

Technavioa's global prenatal vitamin supplements market is segmented as below:

Distribution channelConventional retail channels Direct selling and e-retailing

Geographic segmentation

North America APAC Europe South America MEA

Key Trends for global prenatal vitamin supplements market growth

This study identifies usage of artificial intelligence by prenatal vitamin supplement manufacturing players as the prime reasons driving the global prenatal vitamin supplements market growth during the next few years.

Prominent vendors in global prenatal vitamin supplements market

We provide a detailed analysis of around 25 vendors operating in the global prenatal vitamin supplements market, including some of the vendors such as Abbott Laboratories, Atrium Innovations Inc., Bayer AG, Church & Dwight Co. Inc., FoodState Inc., Nordic Naturals, Nutranext, Otsuka Holdings Co. Ltd., The Procter & Gamble Co. and TherapeuticsMD Inc. .

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavioa's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

Table of Contents

Executive Summary

  • Market Overview

Market Landscape

  • Market ecosystem
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024

Five Forces Analysis

  • Five Forces Summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Distribution channel

  • Market segments
  • Comparison by Distribution channel placement
  • Conventional retail channels - Market size and forecast 2019-2024
  • Direct selling and e-retailing - Market size and forecast 2019-2024
  • Market opportunity by Distribution channel

Customer landscape

  • Overview

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • APAC - Market size and forecast 2019-2024
  • South America - Market size and forecast 2019-2024
  • MEA - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography

Drivers, Challenges, and Trends

  • Market drivers
  • Volume driver - Demand led growth
  • Volume driver - Supply led growth
  • Volume driver - External factors
  • Volume driver - Demand shift in adjacent markets
  • Price driver - Inflation
  • Price driver - Shift from lower to higher priced units
  • Market challenges
  • Market trends

Vendor Landscape

  • Overview
  • Vendor landscape
  • Landscape disruption

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • Abbott Laboratories
  • Atrium Innovations Inc.
  • Bayer AG
  • Church & Dwight Co. Inc.
  • FoodState Inc.
  • Nordic Naturals
  • Nutranext
  • Otsuka Holdings Co. Ltd.
  • The Procter & Gamble Co.
  • TherapeuticsMD Inc.

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

List of Exhibits:

  • 1.Key Finding 1
  • 2.Key Finding 2
  • 3.Key Finding 3
  • 4.Key Finding 4
  • 5.Key Finding 5
  • 6.Key Finding 6
  • 7.Key Finding 7
  • 8.Market in focus
  • 9.Parent market
  • 10.Market characteristics
  • 11.Product / Service portfolio of key vendors included in the market definition
  • 12.Market segments
  • 13.Global - Market size and forecast 2019 - 2024 ($ million)
  • 14.Global market: Year-over-year growth 2019 - 2024 (%)
  • 15.Five forces analysis 2019 & 2024
  • 16.Bargaining power of buyers
  • 17.Bargaining power of suppliers
  • 18.Threat of new entrants
  • 19.Threat of substitutes
  • 20.Threat of rivalry
  • 21.Market condition - Five forces 2019
  • 22.Distribution channel placement - Market share 2019-2024 (%)
  • 23.Comparison by Distribution channel placement
  • 24.Conventional retail channels - Market size and forecast 2019-2024 ($ million)
  • 25.Conventional retail channels - Year-over-year growth 2019-2024 (%)
  • 26.Direct selling and e-retailing - Market size and forecast 2019-2024 ($ million)
  • 27.Direct selling and e-retailing - Year-over-year growth 2019-2024 (%)
  • 28. Market opportunity by Distribution channel
  • 29.Customer landscape
  • 30.Market share by geography 2019-2024 (%)
  • 31.Geographic comparison
  • 32.North America - Market size and forecast 2019-2024 ($ million)
  • 33.North America - Year-over-year growth 2019-2024 (%)
  • 34.Europe - Market size and forecast 2019-2024 ($ million)
  • 35.Europe - Year-over-year growth 2019-2024 (%)
  • 36.APAC - Market size and forecast 2019-2024 ($ million)
  • 37.APAC - Year-over-year growth 2019-2024 (%)
  • 38.South America - Market size and forecast 2019-2024 ($ million)
  • 39.South America - Year-over-year growth 2019-2024 (%)
  • 40.MEA - Market size and forecast 2019-2024 ($ million)
  • 41.MEA - Year-over-year growth 2019-2024 (%)
  • 42.Key leading countries
  • 43.Market opportunity by geography ($ million)
  • 44.Impact of drivers
  • 45.Impact of challenges
  • 46.Landscape disruption
  • 47.Industry risks
  • 48.Vendors covered
  • 49.Market positioning of vendors
  • 50.Abbott Laboratories - Overview (1/3)
  • 51.Abbott Laboratories - Overview (2/3)
  • 52.Abbott Laboratories - Overview (3/3)
  • 53.Abbott Laboratories - Business segments
  • 54.Abbott Laboratories - Key offerings
  • 55.Abbott Laboratories - Key customers
  • 56.Abbott Laboratories - Segment focus
  • 57.Atrium Innovations Inc. - Overview (1/3)
  • 58.Atrium Innovations Inc. - Overview (2/3)
  • 59.Atrium Innovations Inc. - Overview (3/3)
  • 60.Atrium Innovations Inc. - Business segments
  • 61.Atrium Innovations Inc. - Key offerings
  • 62.Atrium Innovations Inc. - Key customers
  • 63.Atrium Innovations Inc. - Segment focus
  • 64.Bayer AG - Overview (1/3)
  • 65.Bayer AG - Overview (2/3)
  • 66.Bayer AG - Overview (3/3)
  • 67.Bayer AG - Business segments
  • 68.Bayer AG - Key offerings
  • 69.Bayer AG - Key customers
  • 70.Bayer AG - Segment focus
  • 71.Church & Dwight Co. Inc. - Overview (1/3)
  • 72.Church & Dwight Co. Inc. - Overview (2/3)
  • 73.Church & Dwight Co. Inc. - Overview (3/3)
  • 74.Church & Dwight Co. Inc. - Business segments
  • 75.Church & Dwight Co. Inc. - Key offerings
  • 76.Church & Dwight Co. Inc. - Key customers
  • 77.Church & Dwight Co. Inc. - Segment focus
  • 78.FoodState Inc. - Overview (1/3)
  • 79.FoodState Inc. - Overview (2/3)
  • 80.FoodState Inc. - Overview (3/3)
  • 81.FoodState Inc. - Product and service
  • 82.FoodState Inc. - Key offerings
  • 83.FoodState Inc. - Key customers
  • 84.FoodState Inc. - Segment focus
  • 85.Nordic Naturals - Overview (1/3)
  • 86.Nordic Naturals - Overview (2/3)
  • 87.Nordic Naturals - Overview (3/3)
  • 88.Nordic Naturals - Business segments
  • 89.Nordic Naturals - Key offerings
  • 90.Nordic Naturals - Key customers
  • 91.Nordic Naturals - Segment focus
  • 92.Nutranext - Overview (1/3)
  • 93.Nutranext - Overview (2/3)
  • 94.Nutranext - Overview (3/3)
  • 95.Nutranext - Business segments
  • 96.Nutranext - Key offerings
  • 97.Nutranext - Key customers
  • 98.Nutranext - Segment focus
  • 99.Otsuka Holdings Co. Ltd. - Overview (1/3)
  • 100.Otsuka Holdings Co. Ltd. - Overview (2/3)
  • 101.Otsuka Holdings Co. Ltd. - Overview (3/3)
  • 102.Otsuka Holdings Co. Ltd. - Business segments
  • 103.Otsuka Holdings Co. Ltd. - Key offerings
  • 104.Otsuka Holdings Co. Ltd. - Key customers
  • 105.Otsuka Holdings Co. Ltd. - Segment focus
  • 106.The Procter & Gamble Co. - Overview (1/3)
  • 107.The Procter & Gamble Co. - Overview (2/3)
  • 108.The Procter & Gamble Co. - Overview (3/3)
  • 109.The Procter & Gamble Co. - Business segments
  • 110.The Procter & Gamble Co. - Key offerings
  • 111.The Procter & Gamble Co. - Key customers
  • 112.The Procter & Gamble Co. - Segment focus
  • 113.TherapeuticsMD Inc. - Overview (1/3)
  • 114.TherapeuticsMD Inc. - Overview (2/3)
  • 115.TherapeuticsMD Inc. - Overview (3/3)
  • 116.TherapeuticsMD Inc. - Business segments
  • 117.TherapeuticsMD Inc. - Key offerings
  • 118.TherapeuticsMD Inc. - Key customers
  • 119.TherapeuticsMD Inc. - Segment focus
  • 120.Currency conversion rates for US$
  • 121.Research Methodology
  • 122.Validation techniques employed for market sizing
  • 123.Information sources
  • 124.List of abbreviations
Back to Top